Sub-Cutaneous Insulin in Hyperglycaemic Emergencies
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Hyperglycaemic emergencies are associated with significant mortality (mortality in Diabetic
Ketoacidosis 0.65 - 3.3% and in HyperOsmolar Non-Ketotic Coma 12 -17%). To reduce morbidity
and mortality, prompt intervention and coma and close monitoring are essential. The study is
designed to investigate whether a simple intervention with a long acting insulin can improve
resolution of acidosis and hyperglycaemia, prevent recurrence of ketoacidosis and shorten
hospital stay.